Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 35, 2022 - Issue 6
74
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Impact of systemic lupus erythematosus on in-hospital outcomes of peripheral artery disease—insight from the National Inpatient Sample database

, MD, , MD, , MDORCID Icon, , MD, , MD, , MD, , MD, , MD & , MD show all
Pages 778-782 | Received 15 Apr 2022, Accepted 27 Jun 2022, Published online: 13 Jul 2022

  • Borchers AT, Naguwa SM, Shoenfeld Y, Gershwin ME. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev. 2010;9(5):A277–A287. doi:10.1016/j.autrev.2009.12.008.
  • Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med. 1976;60(2):221–225. doi:10.1016/0002-9343(76)90431-9.
  • Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003;349(25):2399–2406. doi:10.1056/NEJMoa035471.
  • Frostegård J. Systemic lupus erythematosus and cardiovascular disease. Lupus. 2008;17(5):364–367. doi:10.1177/0961203308089988.
  • Forte F, Buonaiuto A, Calcaterra I, Iannuzzo G, Ambrosino P, Di Minno MND. Association of systemic lupus erythematosus with peripheral arterial disease: a meta-analysis of literature studies. Rheumatology (Oxford). 2020;59(11):3181–3192. doi:10.1093/rheumatology/keaa414.
  • McMahon M, Skaggs B. Pathogenesis and treatment of atherosclerosis in lupus. Rheum Dis Clin North Am. 2014;40(3):475–495. doi:10.1016/j.rdc.2014.04.003.
  • Zeller CB, Appenzeller S. Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors. Curr Cardiol Rev. 2008;4(2):116–122. doi:10.2174/157340308784245775.
  • Maksimowicz-McKinnon K, Selzer F, Manzi S, et al. Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute Dynamic Registry. Circ Cardiovasc Interv. 2008;1(3):201–208. doi:10.1161/CIRCINTERVENTIONS.108.788745.
  • Ajeganova S, Hafström I, Frostegård J. Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case-control study over 10 years. Lupus Sci Med. 2021;8(1):e000454. doi:10.1136/lupus-2020-000454.
  • Bartels CM, Buhr KA, Goldberg JW, et al. Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort. J Rheumatol. 2014;41(4):680–687. doi:10.3899/jrheum.130874.
  • Lu X, Wang Y, Zhang J, et al. Patients with systemic lupus erythematosus face a high risk of cardiovascular disease: a systematic review and meta-analysis. Int Immunopharmacol. 2021;94:107466. doi:10.1016/j.intimp.2021.107466.
  • Katz G, Smilowitz NR, Blazer A, Clancy R, Buyon JP, Berger JS. Systemic lupus erythematosus and increased prevalence of atherosclerotic cardiovascular disease in hospitalized patients. Mayo Clin Proc. 2019;94(8):1436–1443. doi:10.1016/j.mayocp.2019.01.044.
  • Weckerle CE, Niewold TB. The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies. Clin Rev Allergy Immunol. 2011;40(1):42–49. doi:10.1007/s12016-009-8192-4.
  • Washio M, Kiyohara C, Ohta A. Epidemiology of systemic lupus erythematosus. In: Lionaki S, ed. Lupus—New Advances and Challenges. London: IntechOpen; 2019. doi:10.5772/intechopen.84146.
  • Schramm K, Rochon PJ. Gender differences in peripheral vascular disease. Semin Intervent Radiol. 2018;35(1):9–16. doi:10.1055/s-0038-1636515.
  • González LA, Toloza SM, McGwin G Jr, Alarcón GS. Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes. Lupus. 2013;22(12):1214–1224. doi:10.1177/0961203313502571.
  • Kreps A, Paltoo K, McFarlane I. Cardiac manifestations in systemic lupus erythematosus: a case report and review of the literature. Am J Med Case Rep. 2018;6(9):180–183. doi:10.12691/ajmcr-6-9-3.
  • Kim CH, Al-Kindi SG, Jandali B, Askari AD, Zacharias M, Oliveira GH. Incidence and risk of heart failure in systemic lupus erythematosus. Heart. 2017;103(3):227–233. doi:10.1136/heartjnl-2016-309561.
  • Amdur RL, Ashby B, Neville R, Tunstall A, Nguyen BN, Sidawy A. The effect of congestive heart failure on perioperative outcomes in patients undergoing lower extremity revascularization. J Vasc Surg. 2016;63(5):1289–1295. doi:10.1016/j.jvs.2015.11.039.
  • Li Z, Xiao J, Song H, et al. Evaluation of coagulation disorders by thromboelastography in children with systemic lupus erythematosus. Lupus. 2019;28(2):181–188. doi:10.1177/0961203318819137.
  • Wahl DG, Bounameaux H, de Moerloose P, Sarasin FP. Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis. Arch Intern Med. 2000;160(13):2042–2048. doi:10.1001/archinte.160.13.2042.
  • Hoover PJ, Costenbader KH. Insights into the epidemiology and management of lupus nephritis from the US rheumatologist’s perspective. Kidney Int. 2016;90(3):487–492. doi:10.1016/j.kint.2016.03.042.
  • Wang H, Ren YL, Chang J, Gu L, Sun LY. A systematic review and meta-analysis of prevalence of biopsy-proven lupus nephritis. Arch Rheumatol. 2018;33(1):17–25. doi:10.5606/ArchRheumatol.2017.6127.
  • Garimella PS, Hirsch AT. Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes. Adv Chronic Kidney Dis. 2014;21(6):460–471. doi:10.1053/j.ackd.2014.07.005.
  • Anantha-Narayanan M, Sheikh AB, Nagpal S, et al. Impact of kidney disease on peripheral arterial interventions: a systematic review and meta-analysis. Am J Nephrol. 2020;51(7):527–533. doi:10.1159/000508575.
  • Shammas NW. Epidemiology, classification, and modifiable risk factors of peripheral arterial disease. Vasc Health Risk Manag. 2007;3(2):229–234. doi:10.2147/vhrm.2007.3.2.229.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.